ahlam1399
03-29-2016, 03:44 PM
BRIEF-Lannett receives FDA approvals for two products
* Expects to launch temolozomide capsules shortly Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e939338/sc/28/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=dxGrB4AMtPA:R_HBmDU7tUI:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=dxGrB4AMtPA:R_HBmDU7tUI:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=dxGrB4AMtPA:R_HBmDU7tUI:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=dxGrB4AMtPA:R_HBmDU7tUI:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=dxGrB4AMtPA:R_HBmDU7tUI:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/dxGrB4AMtPA
* Expects to launch temolozomide capsules shortly Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e939338/sc/28/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=dxGrB4AMtPA:R_HBmDU7tUI:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=dxGrB4AMtPA:R_HBmDU7tUI:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=dxGrB4AMtPA:R_HBmDU7tUI:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=dxGrB4AMtPA:R_HBmDU7tUI:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=dxGrB4AMtPA:R_HBmDU7tUI:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/dxGrB4AMtPA